Tomas Holm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tomas Holm has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
J. F. Lassen
Department of Cardiology B, Skejby Section; and
1 shared publicationJens F Lassen
1 shared publicationL. Heickendorff
Department of Clinical Biochemistry, Aarhus Amtssygehus
1 shared publicationLene Heickendorff
1 shared publicationP. Christensen
General Practitioner, and GP Adviser, Aarhus Amtssygehus; Aarhus UniversityHospital, Aarhus, Denmark
1 shared publicationS. E. Husted
From the Department of Internal Medicine and Cardiology A, Aarhus Amtssygehus
1 shared publication
Latest Publications
- Open Access
- 4 October 2002
- Published by Wiley in Journal of Internal Medicine
- Vol. 252 (4) , 322-331
A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy
Objectives. To evaluate the effect of a shared careprogramme (SCP), defined as a scheme based on shared responsibility, enhanced information exchange, continues medical education and explicit clinical guidelines, between general practitioners (GPs) and a hospital outpatient clinic (HOC), on oral anticoagulant therapy (OAT).Design. The study was a 2‐year prospective, randomized, controlled trial, preceded by a 1‐year period of observation.Setting. The HOC, GPs, and OAT patients in the admission area of Aarhus University Hospital, Aarhus County, Denmark, covering 310 300 inhabitants.Subjects. A total of 207 GPs, including their enlisted patients on OAT, were invited, and 61.4% accepted participation. They were randomized into an intervention group [group‐INT: 64 GPs and 453 patients (170 patients on OAT throughout the study period, i.e. full follow‐up)], and a control group [group‐CON: 63 GPs and 422 patients (173 with full follow‐up)]. The remaining 80 GPs served as a nonresponder group (group‐NON) of 485 patients (184 with full follow‐up).Main outcome measure. Therapeutic control of OAT in terms of time spent by the patients within the therapeutic interval (TI) of an international normalized ratio (INR) between 2.0 and 3.5.Results. The groups did not differ significantly with regard to age, sex, OAT indication, anticoagulant drug used, or the therapeutic control at baseline. In a comparison based on intention‐to‐treat principles, the therapeutic control increased statistical significance amongst patients with full follow‐up in group‐INT compared with group‐CON (median time within TI: group INT = 86.6% vs. 80.5%, P = 0.007).Conclusion. An SCP of anticoagulant management is effective in reducing patient time outside the therapeutic INR interval in OAT patients randomly assigned to an SCP, as compared with a control group.
- 4 October 2002
- Published by Wiley in Journal of Internal Medicine
- Vol. 252 (4) , 322-331
Open AccessA randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy
Objectives. To evaluate the effect of a shared careprogramme (SCP), defined as a scheme based on shared responsibility, enhanced information exchange, continues medical education and explicit clinical guidelines, between general practitioners (GPs) and a hospital outpatient clinic (HOC), on oral anticoagulant therapy (OAT).Design. The study was a 2‐year prospective, randomized, controlled trial, preceded by a 1‐year period of observation.Setting. The HOC, GPs, and OAT patients in the admission area of Aarhus University Hospital, Aarhus County, Denmark, covering 310 300 inhabitants.Subjects. A total of 207 GPs, including their enlisted patients on OAT, were invited, and 61.4% accepted participation. They were randomized into an intervention group [group‐INT: 64 GPs and 453 patients (170 patients on OAT throughout the study period, i.e. full follow‐up)], and a control group [group‐CON: 63 GPs and 422 patients (173 with full follow‐up)]. The remaining 80 GPs served as a nonresponder group (group‐NON) of 485 patients (184 with full follow‐up).Main outcome measure. Therapeutic control of OAT in terms of time spent by the patients within the therapeutic interval (TI) of an international normalized ratio (INR) between 2.0 and 3.5.Results. The groups did not differ significantly with regard to age, sex, OAT indication, anticoagulant drug used, or the therapeutic control at baseline. In a comparison based on intention‐to‐treat principles, the therapeutic control increased statistical significance amongst patients with full follow‐up in group‐INT compared with group‐CON (median time within TI: group INT = 86.6% vs. 80.5%, P = 0.007).Conclusion. An SCP of anticoagulant management is effective in reducing patient time outside the therapeutic INR interval in OAT patients randomly assigned to an SCP, as compared with a control group.
- 1 August 2002
- Vol. 49 (3) , 252-5
The quality of routine oral anticoagulant therapy in a large geographical area. A survey of 310,300 inhabitants.
To identify all patients undergoing routine oral anticoagulant therapy (OAT) in a large geographic area as well as the quality of OAT. In the admission area of Aarhus County Hospital, Denmark (310,300 inhabitants), we conducted a population-based prospective observational study 1 April 1997 to 31 March 1998, using the Laboratory Information System to identify all patients and their related International Normalized Ratio (INR)-values as well as their monitoring physician. Main outcome measures were, incidence rate, point prevalence and the quality of OAT based on measurement of the time (in days) of INR-values within therapeutic interval (TI) of OAT. 1609 patients (median age: 68.0 years; range 0.2-95.0) corresponding to 1155 patient-years on OAT were identified. 585 patients were started on OAT within the time period, corresponding to an incidence rate of 188 patients/year/100,000 inhabitants. September 1st 1997, 1174 patients were on OAT, equal to a point prevalence of 378 patients/year/100,000 inhabitants. Overall, 71% of treatment time (in days) INR was within the TI. Among patients monitored by an outpatient clinic or by a general practitioner, the time of INR within TI were 76.5% and 69.9%, respectively (p < 0.0001). The result indicates that the quality of routine OAT in this geographical area is in accordance with other similar studies. The quality might be better in the outpatient clinics although the result could be due to selection bias. The method to identify OAT patients is convenient and precise, making continuous surveillance of rate of incidence, point prevalence as well as quality of OAT in large geographic areas, possible.
- 1 August 2002
- Vol. 49 (3) , 252-5
The quality of routine oral anticoagulant therapy in a large geographical area. A survey of 310,300 inhabitants.
To identify all patients undergoing routine oral anticoagulant therapy (OAT) in a large geographic area as well as the quality of OAT. In the admission area of Aarhus County Hospital, Denmark (310,300 inhabitants), we conducted a population-based prospective observational study 1 April 1997 to 31 March 1998, using the Laboratory Information System to identify all patients and their related International Normalized Ratio (INR)-values as well as their monitoring physician. Main outcome measures were, incidence rate, point prevalence and the quality of OAT based on measurement of the time (in days) of INR-values within therapeutic interval (TI) of OAT. 1609 patients (median age: 68.0 years; range 0.2-95.0) corresponding to 1155 patient-years on OAT were identified. 585 patients were started on OAT within the time period, corresponding to an incidence rate of 188 patients/year/100,000 inhabitants. September 1st 1997, 1174 patients were on OAT, equal to a point prevalence of 378 patients/year/100,000 inhabitants. Overall, 71% of treatment time (in days) INR was within the TI. Among patients monitored by an outpatient clinic or by a general practitioner, the time of INR within TI were 76.5% and 69.9%, respectively (p < 0.0001). The result indicates that the quality of routine OAT in this geographical area is in accordance with other similar studies. The quality might be better in the outpatient clinics although the result could be due to selection bias. The method to identify OAT patients is convenient and precise, making continuous surveillance of rate of incidence, point prevalence as well as quality of OAT in large geographic areas, possible.